Skip to Main Content Skip to Site Map Skip to Accessibility Statement

LAMDARCT

 

 

Study Acronym LAMDARCT
Trial Title L-DOPA for neovascular (wet) age-related macular degeneration (AMD)? A Randomised Controlled Trial: LAMDARCT
Clinical Area Ophthalmology
Trial Status Set Up
Chief Investigator (CI) Professor Tunde Peto, Queen’s University Belfast
Sponsor Belfast Health and Social Care Trust
Funder National Institute for Health & Care Research

For any queries regarding this trial please contact the study email (LAMDARCT@nictu.hscni.net) or call the NICTU (028 9615 1447).

 

Quick Links

Services